Produktbild
Michael D. Green

Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation

Buch

Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litiga… Mehr

CHF 45.90

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

Produktdetails


  • ISBN: 978-0-8122-1645-5
  • EAN: 9780812216455
  • Produktnummer: 28194660
  • Verlag: Univ Of Pennsylvania Pr
  • Sprache: Englisch
  • Erscheinungsjahr: 1998
  • Seitenangabe: 384 S.
  • Masse: H22.3 cm x B14.7 cm x D2.6 cm 581 g
  • Auflage: Revised
  • Gewicht: 581

Über den Autor


Michael D. Green is Professor of Law at the University of Iowa.

13 weitere Werke von Michael D. Green:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.